A short-term high-sugar diet is an aggravating factor in experimental allergic contact dermatitis

Carregando...
Imagem de Miniatura
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
CELL PRESS
Autores
COELHO, Leila F.
CASARO, Mateus B.
RIBEIRO, Willian R.
MENDES, Eduardo
XANDER, Patricia
LINO-DOS-SANTOS-FRANCO, Adriana
OLIVEIRA, Fernando A.
FERREIRA, Caroline M.
Citação
HELIYON, v.9, n.11, article ID e21225, 10p, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Allergic contact dermatitis (ACD) is an inflammatory skin reaction whose incidence has increased and has been associated with a dietary pattern rich in saturated fats and refined sugars. Considering the increased incidence of ACD and the lack of research about the influence of a short-term high-sugar diet on dermatitis, our aim is to improve understanding of the influence of a high-sugar diet on ACD. We introduced a diet rich in sugar fifteen days before inducing contact dermatitis with oxazolone, in mice, and maintained it until the end of the experiment, which lasted three weeks in total. The dermatitis model increased cholesterol and triglycerides in the liver, and the combination of diet and dermatitis increased weight and worsened liver cholesterol measurements. Furthermore, the high-sugar diet increased the production of IL-6, IFN-gamma and TNF alpha in the skin, which may be involved in the increase in epithelial skin thickness observed in experimental ACD.
Palavras-chave
Allergy, Dermatitis, Sugar, Diet, Skin, Inflammation
Referências
  1. Aebischer D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099297
  2. Amor S, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010153
  3. BIRCH GG, 1974, J SCI FOOD AGR, V25, P1355, DOI 10.1002/jsfa.2740251103
  4. Botz B, 2016, EXP DERMATOL, V25, P725, DOI 10.1111/exd.13059
  5. Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012
  6. Carr RM, 2016, GASTROENTEROL CLIN N, V45, P639, DOI 10.1016/j.gtc.2016.07.003
  7. Chen CC, 2017, J ACUPUNCT MERIDIAN, V10, P252
  8. Christ A, 2019, IMMUNITY, V51, P794, DOI 10.1016/j.immuni.2019.09.020
  9. Christensen AD, 2012, APMIS, V120, P1, DOI 10.1111/j.1600-0463.2011.02832.x
  10. CUMBERBATCH M, 1992, IMMUNOLOGY, V75, P257
  11. CUMBERBATCH M, 1995, IMMUNOLOGY, V84, P31
  12. De Biase D, 2019, LAB ANIM-UK, V53, P447, DOI 10.1177/0023677218815718
  13. FAHEY TJ, 1991, J SURG RES, V50, P308, DOI 10.1016/0022-4804(91)90196-S
  14. Fallahi P, 2016, CLIN TER, V167, P112, DOI 10.7417/CT.2016.1953
  15. Fujii Y, 2002, EUR J PHARMACOL, V456, P115, DOI 10.1016/S0014-2999(02)02554-2
  16. Gallucci RM, 2000, FASEB J, V14, P2525, DOI 10.1096/fj.00-0073com
  17. Heo MJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61424-1
  18. Hernández-Quintero M, 2006, CELL TISSUE RES, V325, P77, DOI 10.1007/s00441-006-0173-9
  19. Hussain M, 2019, J ALLERGY CLIN IMMUN, V144, P157, DOI 10.1016/j.jaci.2019.01.043
  20. Kalboussi H, 2019, DERMAT RES PRACT, V2019, DOI 10.1155/2019/3797536
  21. Kawano A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127919
  22. Kim SY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150202
  23. Kimata H, 2005, INDIAN PEDIATR, V42, P587
  24. Kulkarni NM, 2015, PHARM BIOL, V53, P1110, DOI 10.3109/13880209.2014.960944
  25. Kumar S, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-21270-9
  26. Laffin M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48749-2
  27. Lee EG, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/5087847
  28. Leonard A, 2019, CLIN REV ALLERG IMMU, V56, P1, DOI 10.1007/s12016-018-8685-0
  29. Litchman G., 2022, Contact Dermatitis, P1, DOI [10.1177/1755738015601448, DOI 10.1177/1755738015601448]
  30. Lowe A, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024594
  31. Maarouf M, 2019, AUSTRALAS J DERMATOL, V60, pE90, DOI 10.1111/ajd.12909
  32. Mahdavinia M, 2019, J ALLERGY CLIN IMMUN, V143, P1636, DOI 10.1016/j.jaci.2018.11.034
  33. Maldonado EM, 2018, NPJ SYST BIOL APPL, V4, DOI 10.1038/s41540-018-0070-3
  34. Man MQ, 2008, J INVEST DERMATOL, V128, P79, DOI 10.1038/sj.jid.5701011
  35. Mantovani A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020217
  36. Masi LN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04308-1
  37. Morrow NM, 2022, BBA-MOL CELL BIOL L, V1867, DOI 10.1016/j.bbalip.2022.159208
  38. Nagano T, 2019, INT J FOOD SCI NUTR, V70, P579, DOI 10.1080/09637486.2018.1547689
  39. Nassau S, 2020, MED CLIN N AM, V104, P61, DOI 10.1016/j.mcna.2019.08.012
  40. Ogdie A, 2018, J INVEST DERMATOL, V138, P760, DOI 10.1016/j.jid.2017.10.024
  41. Oliveira MC, 2013, OBESITY, V21, pE396, DOI [10.1002/oby.20230, 10.1038/oby.20230]
  42. Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4
  43. PIGUET PF, 1991, J EXP MED, V173, P673, DOI 10.1084/jem.173.3.673
  44. Pollock AH, 2016, J IMMUNOL, V196, P3993, DOI 10.4049/jimmunol.1501261
  45. Rottgen TS, 2018, AM J PHYSIOL-CELL PH, V315, pC10, DOI 10.1152/ajpcell.00328.2017
  46. Sakaguchi K, 2016, DIABETOL INT, V7, P53, DOI 10.1007/s13340-015-0212-4
  47. Sasso O, 2018, J INVEST DERMATOL, V138, P562, DOI 10.1016/j.jid.2017.07.853
  48. Savetsky IL, 2015, J INVEST DERMATOL, V135, P2742, DOI 10.1038/jid.2015.283
  49. Schmitt J, 2016, J ALLERGY CLIN IMMUN, V137, P130, DOI 10.1016/j.jaci.2015.06.029
  50. Seino S, 2012, J CLIN BIOCHEM NUTR, V50, P152, DOI 10.3164/jcbn.11-29
  51. Shanmugam N, 2003, DIABETES, V52, P1256, DOI 10.2337/diabetes.52.5.1256
  52. Valero MS, 2020, INFLAMMOPHARMACOLOGY, V28, P1717, DOI 10.1007/s10787-019-00626-0
  53. Van Belle AB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38156-4
  54. Wang BH, 2001, J LEUKOCYTE BIOL, V70, P185
  55. Willart MAM, 2009, CLIN EXP ALLERGY, V39, P12, DOI 10.1111/j.1365-2222.2008.03118.x
  56. Yamada K, 2018, ACTA DERM-VENEREOL, V98, P19, DOI 10.2340/00015555-2807
  57. Zhao Y, 2009, BRIT J DERMATOL, V161, P1301, DOI 10.1111/j.1365-2133.2009.09400.x
  58. Zhong WL, 2022, NAT METAB, V4, DOI 10.1038/s42255-022-00687-6